All In Biotech

Drug Trial Radar · NCT02118896

Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant

A Long-term Follow up Study to Evaluate the Safety and Efficacy in Transplant Recipients Treated With Modified Release Tacrolimus, FK506E (MR4), Based Immunosuppression Regimen

Last checked: Nov 20, 2026Latest source record: Nov 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

850

Actual

Start

Feb 24, 2003

Primary completion

Oct 7, 2009

Study completion Oct 7, 2009

Sponsor

Lead sponsor
Astellas Pharma Europe Ltd.Astellas (ALPMY)
Sponsor type
Industry
First posted
Apr 21, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study was to offer patients who had participated in one of the phase II PK or phase III studies on FK506E (MR4) the possibility to continue FK506E (MR4) until commercial availability of the drug and to record long term efficacy and safety data.

Conditions

  • Heart Transplantation
  • Liver Transplantation
  • Kidney Transplantation

Interventions

  • FK506EDrug

    oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Participant SurvivalTime frame: Up to 5.5 years (66 months (phase II) and 24 months (phase III)).
  2. Graft SurvivalTime frame: Up to 5.5 years ((66 months (phase II) and 30 months (phase III)).

Locations

105 sites in 23 countries. Site status is shown where the registry gives one.

  • University Hospital

    Cincinnati, Ohio

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia

  • Princess Alexandra Hospital

    Brisbane, Queensland, Australia

  • Austin Hospital

    Heidelberg, Victoria, Australia

  • Royal Melbourne Hospital

    Melbourne, Victoria, Australia

  • Landeskrankenhaus Innsbruck

    Innsbruck, Austria

  • AKN Wien

    Vienna, Austria

  • Hospital Erasme

    Brussels, Belgium

  • Cliniques Universitaires St. Luc

    Brussels, Belgium

  • Departement Heelkunde

    Ghent, Belgium

  • Universitair Ziekenhuis Gasthuisberg

    Leuven, Belgium

  • Domaine Universitaire du Sart Tillman

    Liège, Belgium

  • Hospital da Clínicas da UNICAMP

    Campinas, Brazil

  • Hospital São Francisco

    Porto Alegre, Brazil

  • Irmandade da Santa Casa de Misericordia de Porto Alegre

    Porto Alegre, Brazil

  • Hospital Geral de Bonsucesso

    Rio de Janeiro, Brazil

  • Vancouver Hospital & Health Sciences Centre

    Vancouver, Canada

  • University of Alberta

    Edmonton, Alberta, Canada

  • London Health Sciences Centre

    London, Ontario, Canada

  • University of Ottawa Heart Institute

    Ottawa, Ontario, Canada

  • Institut de Cardiologie de Montréal

    Montreal, Quebec, Canada

  • Centre Hospitalier de l'Universite de Montreal (CHUM)

    Montreal, Quebec, Canada

  • Royal Victoria Hospital

    Montreal, Quebec, Canada

  • IKEM

    Prague, Czechia

  • Skejby University Hospital

    Århus N, Denmark

  • Helsinki University Central Hospital

    Helsinki, Finland

  • Hôpital Beaujon

    Clichy, France

  • Hôpital Henri Mondor

    Créteil, France

  • Hôpital Henri Mondor

    Créteil, France

  • Chu Nord

    Grenoble, France

  • CHU Saint-Etienne

    Saint-Etienne, France

  • Hôpital Hautepierre

    Strasbourg, France

  • Hopital Paul Brousse

    Villejuif, France

  • Hôpital Bicêtre

    Le Kremlin-Bicêtre, Bicetre Cedex, France

  • Hôpital Calmette

    Lille, Cedex, France

  • Hopital Pontchaillou

    Rennes, Cedex, France

  • Hopital Saint-Eloi

    Montpellier, Cedex 05, France

  • Hopital Laennec

    Nantes, Cedex 1, France

  • Hotel Dieu

    Nantes, Cedex 1, France

  • Service de Nephrologie

    Nice, Cedex 1, France

Showing 40 of 105 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.